Henk-Andre Kroon
Company: Annexon Biosciences
Job title: Senior Vice President & Head of Translational Medicine
Seminars:
Panel Discussion: Navigating the Clinical Challenges as Complement Inhibitors are Applied to Larger Patient Populations 10:30 am
Discussing the critical considerations for managing systemic complement inhibition and minimizing off-target effects and infection risks in a diverse patient cohort Overcoming diagnostic and biomarker limitations to accurately identify which patients within larger populations will truly benefit from complement inhibition Exploring innovative drug delivery modalities are essential to improve patient convenience and adherence for chronic…Read more
day: Conference Day One
Complement-Neutrophil Axis: Drivers of Neuroinflammation & Tissue Injury 12:40 pm
Explaining how complement activation products like C5a attract and activate neutrophils, creating a key inflammatory axis Detailing how the complement-neutrophil interaction fuels neuroinflammation, leading to the release of pro-inflammatory mediators Connecting this sustained neuroinflammation to direct tissue damage in various neurological disordersRead more
day: Conference Day One